Viral
Hepatitis
-
-
0
FDA approves Merck & Co.’s Ebola vaccine Ervebo: January’s industry headlines
-
0
US FDA warns of serious liver injury linked to hepatitis C drugs: September’s industry headlines
Herpes
-
0
ASM Microbe: What consequences could lifelong Epstein–Barr virus infection have for the brain?
-
0
HR-HPV oral infection rates in England are lower than expected
-
0
A peek behind the paper – Lynn Enquist on the lifecycle of alpha herpesvirus
HIV / AIDS
-
0
Losing control of HIV: KLF2 could trigger impaired T-cell function
-
0
HIV stem cell therapy on the horizon by regenerating damaged cells in the gut
-
0
Novel adjuvant helps extend immunity against HIV in primates
HPV
-
0
FDA approves Merck & Co.’s Ebola vaccine Ervebo: January’s industry headlines
-
0
Could widespread HPV vaccination eliminate cervical cancer?
-
0
Understanding human papillomaviruses using organotypic 3D models – an interview with Sally Roberts
Influenza
-
0
Universal vaccines: A holy grail for the flu?
-
0
Could obesity promote virulence in influenza?
-
0
The lessons of flu blogging
Varicella Zoster
-
0
ECCMID18: Research suggests measles remains a ‘serious threat’ to those under two years old
-
0
Can social media trends predict population vaccinating behavior?
-
0
MMR vaccination: Pro-vaccination strategies fail to debunk popular misconceptions
West Nile
-
0
ECCMID18: Is West Nile virus re-emerging in Greece?
-
0
Malarial drug resistance and congenital complications – the week in infectious diseases
-
0
Could close relatives of the Zika virus also induce birth defects?